Search For "key starting material ksm"
Pharma sector revenue, margins likely to remain healthy in FY22: ICRA
Updated : 5 years, 5 months ago IST
New Delhi [India], December 24 (ANI): With inelastic demand for drugs and resumption of production to the near pre-Covid levels by Q3 FY21, revenue growth for Indian pharmaceutical market is expected to be 7 to 9 per cent in FY21 despite muted growth in Q1 FY21, according to investment infor
Read More